Robert F. Gilfillan

610 total citations
20 papers, 453 citations indexed

About

Robert F. Gilfillan is a scholar working on Infectious Diseases, Parasitology and Molecular Biology. According to data from OpenAlex, Robert F. Gilfillan has authored 20 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Parasitology and 3 papers in Molecular Biology. Recurrent topics in Robert F. Gilfillan's work include Vector-borne infectious diseases (4 papers), Viral Infections and Vectors (4 papers) and Mosquito-borne diseases and control (3 papers). Robert F. Gilfillan is often cited by papers focused on Vector-borne infectious diseases (4 papers), Viral Infections and Vectors (4 papers) and Mosquito-borne diseases and control (3 papers). Robert F. Gilfillan collaborates with scholars based in United States and Ireland. Robert F. Gilfillan's co-authors include George F. Grady, Anthony J. Sbarra, Wadi A. Bardawil, D. Frank Holtman, David M. Bell, Ivor Berkowitz, Herta Wulff, Sarah H. Cheeseman, John F. Modlin and Joel L. Nitzkin and has published in prestigious journals such as Nature, New England Journal of Medicine and Annals of Internal Medicine.

In The Last Decade

Robert F. Gilfillan

20 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert F. Gilfillan United States 11 137 104 95 85 80 20 453
A Rodríguez‐Torres Spain 10 66 0.5× 92 0.9× 26 0.3× 33 0.4× 37 0.5× 29 406
Patrick Collard United Kingdom 13 58 0.4× 110 1.1× 12 0.1× 31 0.4× 84 1.1× 62 505
Fumiya Sato Japan 12 93 0.7× 148 1.4× 113 1.2× 38 0.4× 222 2.8× 51 611
C P van Boven Netherlands 10 64 0.5× 90 0.9× 35 0.4× 17 0.2× 108 1.4× 14 458
Marcia A. Kielhofner United States 11 48 0.4× 148 1.4× 39 0.4× 75 0.9× 77 1.0× 15 390
G. H. Cassell United States 13 74 0.5× 70 0.7× 121 1.3× 89 1.0× 51 0.6× 24 558
Melvin S. Rheins United States 14 18 0.1× 119 1.1× 27 0.3× 73 0.9× 82 1.0× 61 618
Zemira Samra Israel 15 115 0.8× 103 1.0× 41 0.4× 123 1.4× 96 1.2× 34 529
K. Lily Therese India 14 114 0.8× 200 1.9× 39 0.4× 53 0.6× 131 1.6× 50 827
L J La Scolea United States 12 36 0.3× 77 0.7× 16 0.2× 68 0.8× 52 0.7× 20 471

Countries citing papers authored by Robert F. Gilfillan

Since Specialization
Citations

This map shows the geographic impact of Robert F. Gilfillan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Gilfillan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Gilfillan more than expected).

Fields of papers citing papers by Robert F. Gilfillan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Gilfillan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Gilfillan. The network helps show where Robert F. Gilfillan may publish in the future.

Co-authorship network of co-authors of Robert F. Gilfillan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Gilfillan. A scholar is included among the top collaborators of Robert F. Gilfillan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Gilfillan. Robert F. Gilfillan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reid, Mark, Wilson Caulfield, Ola Epemolu, et al.. (2010). The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(12). 3713–3716. 6 indexed citations
2.
Gilfillan, Robert F., et al.. (1988). Evaluation of Rapid Enzyme Immunoassay for Canine Lyme Disease Antibody Detection. Annals of the New York Academy of Sciences. 539(1). 447–448. 4 indexed citations
3.
Gilfillan, Robert F., et al.. (1988). Detection of Lyme Disease in Dogs by Indirect Immunofluorescent Antibody Assays. Annals of the New York Academy of Sciences. 539(1). 458–459. 4 indexed citations
4.
Marcus, Leonard C., et al.. (1985). Antibodies to Borrelia burgdorferi in New England horses: Serologic survey. American Journal of Veterinary Research. 46(12). 2570–2571. 24 indexed citations
5.
Hildreth, Stephen W., et al.. (1984). Detection of Eastern Equine Encephalomyelitis Virus and Highlands J Virus Antigens within Mosquito Pools by Enzyme Immunoassay (EIA). American Journal of Tropical Medicine and Hygiene. 33(5). 973–980. 21 indexed citations
6.
Sakamoto, Kiyoshi, John M. Greally, Robert F. Gilfillan, et al.. (1982). Epstein‐Barr Virus in Normal Pregnant Women*. American journal of reproductive immunology. 2(4). 217–221. 22 indexed citations
7.
Bell, David M., Edward W. Brink, Joel L. Nitzkin, et al.. (1981). Kawasaki Syndrome: Description of Two Outbreaks in the United States. New England Journal of Medicine. 304(26). 1568–1575. 143 indexed citations
8.
Etkind, Paul, et al.. (1981). Epidemic Typhus (Rickettsia prowazekii) in Massachusetts: Evidence of Infection. New England Journal of Medicine. 304(19). 1166–1168. 9 indexed citations
9.
Grady, George F. & Robert F. Gilfillan. (1979). Relation of Mycoplasma pneumoniae Seroreactivity, Immunosuppression, and Chronic Disease to Legionnaires' Disease. Annals of Internal Medicine. 90(4). 607–610. 41 indexed citations
10.
Grady, George F., Stephen W. Hildreth, Ralph Timperi, et al.. (1978). EASTERN EQUINE ENCEPHALITIS IN MASSACHUSETTS, 1957–1976. American Journal of Epidemiology. 107(2). 170–178. 30 indexed citations
11.
Gilfillan, Robert F., et al.. (1977). Acute Parotitis Associated with Influenza Type a. New England Journal of Medicine. 296(24). 1391–1392. 21 indexed citations
12.
Gilfillan, Robert F.. (1968). Phagocytosis and degradation of elastin by normal and tumor cells in culture.. PubMed. 28(1). 137–47. 11 indexed citations
13.
Sbarra, Anthony J., John S. Baumstark, Robert F. Gilfillan, & Wadi A. Bardawil. (1963). Elastase Production By Micro-Organisms. Nature. 197(4863). 153–155. 6 indexed citations
14.
Sbarra, Anthony J., Robert F. Gilfillan, & Wadi A. Bardawil. (1960). A Plate Assay for Elastase. Nature. 188(4747). 322–323. 57 indexed citations
15.
Sbarra, Anthony J., Robert F. Gilfillan, & Wadi A. Bardawil. (1960). The hexose monophosphate pathway in arterial tissue. Biochemical and Biophysical Research Communications. 3(3). 311–313. 5 indexed citations
16.
Gilfillan, Robert F., et al.. (1956). INFLUENCE OF SALMONELLA PULLORUM INFECTION ON VARIOUS LIVER TRICARBOXYLIC ACID ENZYMES AND CITRATE LEVELS IN THE CHICK. Journal of Bacteriology. 72(5). 624–627. 14 indexed citations
17.
Gilfillan, Robert F., et al.. (1956). MODIFICATION OF PULLORUM DISEASE IN THE CHICK BY CERTAIN TRICARBOXYLIC ACID CYCLE INHIBITORS AND INTERMEDIATES. Journal of Bacteriology. 72(5). 620–623. 8 indexed citations
18.
Gilfillan, Robert F., et al.. (1955). A Synthetic Medium for Propagation and Maintenance of Virulent Strains of Salmonella pullorum. Poultry Science. 34(6). 1283–1288. 5 indexed citations
19.
Holtman, D. Frank, et al.. (1955). THE EFFECT OF SALMONELLA PULLORUM INFECTION ON AMINO ACIDS OF THE CHICK. Journal of Bacteriology. 70(3). 272–275. 15 indexed citations
20.
Holtman, D. Frank, et al.. (1955). THE EFFECT OF THE INTRODUCTION OF AMINO ACIDS INTO CHICKS INFECTED WITH SALMONELLA PULLORUM. Journal of Bacteriology. 70(3). 276–278. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026